the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Israeli president denies Trump conversation on Netanyahu pardon

Israeli President Isaac Herzog’s office denies a conversation with Donald Trump regarding a pardon request for PM Netanyahu on corruption charges.

JERUSALEM: Israeli President Isaac Herzog has denied former US President Donald Trump’s claim that they discussed a pardon for Prime Minister Benjamin Netanyahu.

Trump stated during a press conference that he had spoken with Herzog and was confident a pardon was forthcoming for Netanyahu, who faces corruption charges.

“There has not been a conversation between President Herzog and President Trump since the pardon request was submitted,” Herzog’s office clarified in a statement.

The office confirmed a representative for Trump had enquired weeks ago about a letter Trump sent regarding the pardon.

Herzog’s office explained that the representative was informed any decision would follow established legal procedures.

Netanyahu is accused of accepting over $260,000 in luxury gifts and seeking favourable media coverage in exchange for political favours.

He has labelled the ongoing trial, which began in 2019, a “political trial” and denies all wrongdoing.

Trump, standing with Netanyahu in Florida, called the Israeli leader a “wartime prime minister who is a hero” and questioned why he would not be pardoned.

A fourth corruption charge against Netanyahu was previously dismissed by the courts.

The Israeli prime minister is the first sitting premier in the country’s history to stand trial for corruption.

Trump has frequently accused his own opponents of weaponising the US justice system against him.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings